Heart Failure [ACCF/AHA]

Heart Failure

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/176034

Contents of this Issue

Navigation

Page 10 of 57

Table 5. Selected Causes of Elevated Natriuretic Peptide Concentrations Cardiac •  HF, including RV syndromes •  ACS •  Heart muscle disease, including LVH •  Valvular heart disease •  Pericardial disease •  AF •  Myocarditis •  Cardiac surgery •  Cardioversion Noncardiac •  Advancing age •  Anemia •  Renal failure •  Pulmonary causes: obstructive sleep apnea, severe pneumonia, pulmonary hypertension •  Critical illness •  Bacterial sepsis •  Severe burns •  Toxic-metabolic insults, including cancer chemotherapy and envenomation Table 6. Recommendations for Biomarkers in HF Biomarker, Application Setting COR LOE I A I A Natriuretic Peptides Diagnosis or exclusion of HF Ambulatory, acute Prognosis of HF Ambulatory, acute Achieve GDMT Ambulatory IIa B Guidance for acute decompensated HF therapy Acute IIb C I A Biomarkers of Myocardial Injury Additive risk stratification Acute, ambulatory Biomarkers of Myocardial Fibrosis Additive risk stratification Ambulatory IIb B Acute IIb A 9

Articles in this issue

Archives of this issue

view archives of Heart Failure [ACCF/AHA] - Heart Failure